Viatris’ Mylan No Longer Subject of DOJ Antitrust Investigation

DOJ no longer considers Mylan, and its former President, Rajiv Malik, a subject of its antitrust investigation in the generic drug industry, according to a Viatris statement.

• DOJ’s civil division informs Viatris it doesn’t expect to take any further actions in connection with a civil investigative demand related to the pricing and sales of generic drug products

To view the source of this information, click here

To contact the reporter on this story:
Wout Vergauwen in Amsterdam at wvergauwen@bloomberg.net

To contact the editor responsible for this story:
Veronica Ek at vek@bloomberg.net

© 2024 Bloomberg L.P. All rights reserved. Used with ...